BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21369464)

  • 21. 23-Gauge transconjunctival sutureless pars plana vitrectomy: results of a prospective study.
    Schweitzer C; Delyfer MN; Colin J; Korobelnik JF
    Eye (Lond); 2009 Dec; 23(12):2206-14. PubMed ID: 19169238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term outcomes of 23-gauge pars plana vitrectomy.
    Gupta OP; Ho AC; Kaiser PK; Regillo CD; Chen S; Dyer DS; Dugel PU; Gupta S; Pollack JS
    Am J Ophthalmol; 2008 Aug; 146(2):193-197. PubMed ID: 18547538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sutureless vitreoretinal surgery using a new 25-gauge transconjunctival system.
    Yoon YH; Kim DS; Kim JG; Hwang JU
    Ophthalmic Surg Lasers Imaging; 2006; 37(1):12-9. PubMed ID: 16468546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repair of primary rhegmatogenous retinal detachment using 25-gauge transconjunctival sutureless vitrectomy.
    Lai MM; Ruby AJ; Sarrafizadeh R; Urban KE; Hassan TS; Drenser KA; Garretson BR
    Retina; 2008 May; 28(5):729-34. PubMed ID: 18463517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of silicone oil tamponade on self-sealing sclerotomy using 25-gauge transconjunctival sutureless vitrectomy: a retrospective comparative study.
    Takashina H; Watanabe A; Tsuneoka H
    BMC Ophthalmol; 2015 Dec; 15():171. PubMed ID: 26626403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of 20-gauge transconjunctival cannulated sutureless vitrectomy using silicone oil or air tamponade.
    Mohamed AA; Abdrabbo M
    Clin Ophthalmol; 2013; 7():379-84. PubMed ID: 23450243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outcomes of 110 consecutive 25-gauge transconjunctival sutureless pars plana vitrectomies].
    Guyomarch J; Delyfer MN; Korobelnik JF
    J Fr Ophtalmol; 2008 May; 31(5):473-80. PubMed ID: 18641579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment.
    Yanyali A; Celik G; Dincyildiz A; Horozoglu F; Nohutcu AF
    Int J Ophthalmol; 2012; 5(2):226-30. PubMed ID: 22762056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Outcomes of 27G(+) transconjunctival sutureless vitrectomy for posterior segment disease].
    Liu JP; Shao Y; Li XR
    Zhonghua Yan Ke Za Zhi; 2018 Dec; 54(12):918-922. PubMed ID: 30526791
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of efficacy and safety between transconjunctival 23-gauge and conventional 20-gauge vitrectomy systems in macular surgery.
    Goncu T; Gurelik G; Hasanreisoglu B
    Korean J Ophthalmol; 2012 Oct; 26(5):339-46. PubMed ID: 23060720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of 23-Gauge Transconjunctival Sutureless Vitrectomy in Patients with Diabetic Retinopathy.
    Pasaoglu I; Cakir M
    Beyoglu Eye J; 2021; 6(3):243-248. PubMed ID: 35005523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 25-Gauge vitrectomy for paediatric vitreoretinal conditions.
    Gonzales CR; Singh S; Schwartz SD
    Br J Ophthalmol; 2009 Jun; 93(6):787-90. PubMed ID: 19211601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of complications in 25-gauge transconjunctival sutureless vitrectomy based on the surgical indications.
    Amato JE; Akduman L
    Ophthalmic Surg Lasers Imaging; 2007; 38(2):100-2. PubMed ID: 17396688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy.
    Ibarra MS; Hermel M; Prenner JL; Hassan TS
    Am J Ophthalmol; 2005 May; 139(5):831-6. PubMed ID: 15860288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary 23-gauge transconjunctival sutureless vitrectomy for rhegmatogenous retinal detachment.
    Tsang CW; Cheung BT; Lam RF; Lee GK; Yuen CY; Lai TY; Lam DS
    Retina; 2008 Oct; 28(8):1075-81. PubMed ID: 18779713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease.
    Lakhanpal RR; Humayun MS; de Juan E; Lim JI; Chong LP; Chang TS; Javaheri M; Fujii GY; Barnes AC; Alexandrou TJ
    Ophthalmology; 2005 May; 112(5):817-24. PubMed ID: 15878061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
    Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
    Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sutureless transconjunctival 20-gauge vitrectomy].
    Dassie-Ajdid J; Mahieu L; Mathis V; Arné JL; Auriol S
    J Fr Ophtalmol; 2011 Dec; 34(10):729-36. PubMed ID: 22001624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active Silicone Oil Removal with a Transconjunctival Sutureless System: Is the 23-Gauge System Safe and Effective?
    Kaya M; Özyurt A; Öztürk AT; Er D; Kaynak S; Koçak N
    Turk J Ophthalmol; 2016 Jan; 46(1):11-15. PubMed ID: 27800251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal detachment surgery with silicone oil injection in transconjunctival sutureless 23-gauge vitrectomy.
    Siqueira RC; Gil AD; Jorge R
    Arq Bras Oftalmol; 2007; 70(6):905-9. PubMed ID: 18235897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.